Combination Influenza/COVID-19 Vaccine Enters Phase 3 Trial, First Participant Dosed
The investigational combination vaccine against influenza and SARS-CoV-2 proved both safe and effective in recent results from a phase 1/2 trial, said Moderna.
Daily Dose: Obesity Before and During Pregnancy Predicts Future CV Health
Your daily dose of the clinical news you may have missed.
FDA Approves Pentavalent Meningococcal Vaccine from Pfizer for Ages 10 to 25 years
The Pfizer product is the first vaccine indicated to prevent the 5 most common serogroups causing meningococcal disease in adolescents and young adults.
Tirzepatide Ranked Most Effective GLP-1 Mimetic for Obesity Management in New Meta-Analysis
The 2 highest doses of tirzepatide were ranked most likely to be effective for weight management in persons without diabetes, followed by semaglutide 2.4 mg.
Next Generation Cologuard Outperforms FIT for CRC Detection, Shows Improved Sensitivity, Specificity
A pivotal phase 3 clinical trial showed Cologuard significantly more likely than FIT to detect cancerous and advanced precancerous lesions.
Hydrocortisone Bests Other Corticosteroids for Community-Acquired Pneumonia in New Analysis
Data presented at CHEST 2023 shows treatment with hydrocortisone is associated with a decrease in morality among patients with community-acquired pneumonia.
10 Top Studies from IDWeek for Primary Care, In Case you Missed Them
IDWeek was packed with so much new science it was hard to make choices. Here we topline 10 with outcomes of interest to primary care, ICYMI.
Daily Dose: Social Risk Factors for RSV Hospitalization in Older Adults
New Data on Alzheimer Disease Research from Biogen Planned for Release at CTAD 2023 Meeting
At the Clinical Trials on Alzheimer's Disease Meeting, October 24-28, the biotech company will update research on lecanemab, aducanumab, and an early-stage disease treatment.
Migraine Medicine in Motion: Jessica Ailani, MD, Discusses CGRP, PACAP, and Patient Selection
Ailiani, director of MedStar Georgetown Headache Center, focuses on optimizing treatment with CGRP inhibitors and where research on PACAP-targeting agents stands now.
Obesity, Severe Obesity Increase Risk for Breast Cancer Recurrence
In postmenopausal women with HR+ breast cancer who had obesity, recurrence of breast cancer while on aromatase inhibitor therapy was 18%, report investigators.
Obesity and Hypertension: It’s a Complicated Relationship, Says One Clinician
President of the Alabama Obesity Society, Dr Jonathan Parker, provides an in-depth overview of the association between obesity and hypertension.
7 New Approved Drugs for Primary Care: Q3 2023
First nonprescription daily oral contraceptive pill, OTC opioid antagonist nasal spray for opioid overdose, and 5 more FDA-approved drugs primary care clinicians should know about.
Daily Dose: Coadministration of RSV and Flu Vaccines in Older Adults
13 Reasons Patients Give for Not Getting a COVID-19 Vaccine Booster
Reasons for not getting a COVID-19 booster ranged from worry about taking time off to believing it won't add any additional protection from infection.
AHA Defines Cardiovascular-Kidney-Metabolic Syndrome, Redefines CVD Risk, Prevention, Management
A new paradigm for reducing CV morbidity and mortality provides a comprehensive approach to comorbid metabolic disease including early detection and treatment.
Universal Masking in Health Care Settings: Poised for Return?
IDWeek 2023: Infectious disease specialist, Gopi Patel, MD, discusses universal masking in health care settings.
Daily Dose: Maintenance Therapy Utilization Suboptimal Before Asthma Exacerbations
Obesity Before, During Pregnancy Key to Future Cardiovascular Risk, New Research Suggests
A novel study strongly suggests that pre-pregnancy obesity rather than associated adverse pregnancy outcomes is the "culprit" in postpartum heart disease.
ID Specialist Underscores Vital Role of Vaccination among Health Care Professionals this Flu Season at IDWeek 2023
Clinicians must remember the point of vaccines was not to prevent infection, but to decrease severity of illness, says infectious disease specialist Gopi Patel, MD.
